Reaction Details  Report a problem with these data
Target
Somatostatin receptor type 5
Ligand
BDBM50059093
Substrate
n/a
Meas. Tech.
ChEMBL_200532 (CHEMBL806602)
IC50
1.04±n/a nM
Citation
 Melacini, G; Zhu, Q; Osapay, G; Goodman, M A refined model for the somatostatin pharmacophore: conformational analysis of lanthionine-sandostatin analogs. J Med Chem 40:2252-8 (1997) [PubMed]  Article
Target
Name:
Somatostatin receptor type 5
Synonyms:
SOMATOSTATIN SST5 | SSR5_RAT | Somatostatin receptor | Somatostatin receptor type 5 | Sstr5
Type:
Enzyme Catalytic Domain
Mol. Mass.:
39986.50
Organism:
RAT
Description:
SOMATOSTATIN SST5 SSTR5 RAT::P30938
Residue:
363
Sequence:
MEPLSLASTPSWNASAASSGNHNWSLVGSASPMGARAVLVPVLYLLVCTVGLSGNTLVIYVVLRHAKMKTVTNVYILNLAVADVLFMLGLPFLATQNAVVSYWPFGSFLCRLVMTLDGINQFTSIFCLMVMSVDRYLAVVHPLRSARWRRPRVAKMASAAVWVFSLLMSLPLLVFADVQEGWGTCNLSWPEPVGLWGAAFITYTSVLGFFGPLLVICLCYLLIVVKVKAAGMRVGSSRRRRSEPKVTRMVVVVVLVFVGCWLPFFIVNIVNLAFTLPEEPTSAGLYFFVVVLSYANSCANPLLYGFLSDNFRQSFRKVLCLRRGYGMEDADAIEPRPDKSGRPQATLPTRSCEANGLMQTSRI
  
Inhibitor
Name:
BDBM50059093
Synonyms:
2-{[10-(4-Amino-butyl)-19-(2-amino-3-phenyl-propionylamino)-16-benzyl-7-(1-hydroxy-ethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicosane-4-carbonyl]-amino}-3-hydroxy-butyric acid | CHEMBL415860
Type:
Small organic molecule
Emp. Form.:
C49H64N10O11S2
Mol. Mass.:
1033.223
SMILES:
C[C@@H](O)[C@@H](NC(=O)[C@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N1)C(O)=O
Structure:
Search PDB for entries with ligand similarity: